Fund shareholders of Voyager Therapeutics Inc
ISIN US92915B1061 · United States · LEI 54930082S4XVR0ZWCC74
- Fund shareholders
- 130
- Of which ETFs
- 24 106 other funds
- Value held
- 35.2M $
- Share of capital
- 14.7 % of 61.6M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,721 | 10.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 2,700 | 10.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 2,518 | 9.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 2,514 | 9.4K $ | 0.18 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 2,258 | 8.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 2,141 | 8.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,054 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,018 | 8.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,953 | 8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,748 | 6.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,722 | 6.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,516 | 6.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,266 | 4.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,206 | 4.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,200 | 4.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,164 | 4.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,100 | 4.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 842 | 3.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Omni Small-Cap Value Fund Bridgeway Funds, Inc. | 600 | 2.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 527 | 2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 496 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 237 | 914.8 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 156 | 602.2 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 118 | 455.5 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 109 | 420.7 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 85 | 317.1 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 65 | 250.9 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 48 | 196.8 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 53.3 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 13 | 50.2 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.47 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.26 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.18 % | as of Apr 30, 2026 ↗ |
| Allspring Disciplined Small Cap Fund ALLSPRING FUNDS TRUST | 0.12 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 0.08 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 0.04 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF Goldman Sachs ETF Trust | 0.03 % | as of Feb 28, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 0.02 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 0.02 % | as of Feb 27, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 130 | -6 | 9,085,533 | -2.4 % |
| 2026Q1 | 136 | -5 | 9,311,361 | -4.7 % |
| 2025Q4 | 141 | 0 | 9,769,075 | -2.2 % |
| 2025Q3 | 141 | -11 | 9,989,011 | -1.5 % |
| 2025Q2 | 152 | -1 | 10,138,960 | -1.9 % |
| 2025Q1 | 153 | -11 | 10,335,390 | -3.3 % |
| 2024Q4 | 164 | -12 | 10,684,559 | -12.6 % |
| 2024Q3 | 176 | -4 | 12,226,381 | +3.8 % |
| 2024Q2 | 180 | +20 | 11,776,692 | +40.2 % |
| 2024Q1 | 160 | +1 | 8,399,354 | +2.8 % |
| 2023Q4 | 159 | 8,171,694 |
Institutional managers
129 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 5,568,381 | 21.5M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 3,500,000 | 13.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,428,571 | 13.2M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 3,002,936 | 11.6M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 1,150,000 | 4.4M $ | as of Mar 31, 2026 |
| Erste Asset Management GmbH | 1,095,141 | 4.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,049,978 | 4.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 948,226 | 3.7M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 875,568 | 3.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 681,711 | 2.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 615,660 | 2.4M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 578,024 | 2.2M $ | as of Mar 31, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 469,761 | 1.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 427,597 | 1.7M $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 423,642 | 1.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 384,843 | 1.5M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 364,664 | 1.4M $ | as of Mar 31, 2026 |
| Fiduciary Trust Co | 334,397 | 1.3M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 276,867 | 1.1M $ | as of Mar 31, 2026 |
| Altshuler Shaham Ltd | 273,925 | 1.1M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 268,223 | 1M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 248,871 | 957 $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 232,681 | 898.1K $ | as of Mar 31, 2026 |
| Patriot Financial Group Insurance Agency, LLC | 205,732 | 794.1K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 193,984 | 748.8K $ | as of Mar 31, 2026 |
Declared shareholders of Voyager Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 5.87 % | 3,500,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| EcoR1 Capital, LLC and 2 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Voyager Therapeutics Inc". https://titelia.com/en/stocks/voyager-therapeutics-inc-US92915B1061